Chemical Component Summary | |
---|---|
Name | ISPINESIB MESILATE |
Identifiers | N-(3-azanylpropyl)-N-[(1R)-1-[7-chloranyl-4-oxidanylidene-3-(phenylmethyl)quinazolin-2-yl]-2-methyl-propyl]-4-methyl-benzamide |
Formula | C30 H33 Cl N4 O2 |
Molecular Weight | 517.062 |
Type | NON-POLYMER |
Isomeric SMILES | Cc1ccc(cc1)C(=O)N(CCCN)[C@@H](C2=Nc3cc(ccc3C(=O)N2Cc4ccccc4)Cl)C(C)C |
InChI | InChI=1S/C30H33ClN4O2/c1-20(2)27(34(17-7-16-32)29(36)23-12-10-21(3)11-13-23)28-33-26-18-24(31)14-15-25(26)30(37)35(28)19-22-8-5-4-6-9-22/h4-6,8-15,18,20,27H,7,16-17,19,32H2,1-3H3/t27-/m1/s1 |
InChIKey | QJZRFPJCWMNVAV-HHHXNRCGSA-N |
Chemical Details | |
---|---|
Formal Charge | 0 |
Atom Count | 70 |
Chiral Atom Count | 1 |
Bond Count | 73 |
Aromatic Bond Count | 18 |
Drug Info: DrugBank
DrugBank ID | DB06188 |
---|---|
Name | Ispinesib |
Groups | investigational |
Synonyms |
|
Indication | Investigated for use/treatment in breast cancer, lung cancer, solid tumors, renal cell carcinoma, pediatric indications, ovarian cancer, and head and neck cancer. |
Categories |
|
CAS number | 336113-53-2 |
Related Resource References
Resource Name | Reference |
---|---|
Pharos | CHEMBL228814 |
PubChem | 6851740 |
ChEMBL | CHEMBL228814 |
ChEBI | CHEBI:94692 |